Prince Foundation Extends Support for Children's Healthcare in Cambodia Through Cambodia Kantha Bopha Foundation, Reflecting Commitment Guided by Neak Oknha Chen Zhi
As part of its continued engagement with CKF, Prince Foundation also led a company-wide internal donation drive across all business units of Prince Holding Group. The initiative invited employees to contribute to solidarity with the national effort, reflecting the shared belief across the organization in supporting access to free pediatric healthcare. Staff gathered at the Group's headquarters in Phnom Penh to make their donations, reinforcing a culture of giving that aligns with the Foundation's values.
The 2025 CKF campaign, under the theme "10K Riel, 10K Donors," encourages individuals and organizations to donate 10,000 Cambodian Riel (approximately US$2.50) each to sustain the critical services offered by Kantha Bopha hospitals, which provide free, life-saving medical care for children throughout the country.
"Healthcare is a shared responsibility, and we are committed to standing with others in supporting Cambodia's children," said Mr. Gabriel Tan, Head of Prince Foundation. "We are proud of the enthusiastic participation of our colleagues across Prince Group, and we hope more members of the public and private sectors will join in contributing to this meaningful campaign."
Since 2015, Prince Foundation—guided by the philanthropic vision of Neak Oknha Chen Zhi — has contributed to the Cambodia Kantha Bopha Foundation, as part of a long-standing commitment to support sustainable and inclusive healthcare in Cambodia.
Prince Foundation encourages others to support this important initiative and contribute to ensuring all children in Cambodia can access the healthcare they need to grow and thrive.
For more information about the Cambodia Kantha Bopha Foundation and how to contribute, please visit https://www.facebook.com/ckf.org.kh/.
Hashtag: #PrinceFoundation
The issuer is solely responsible for the content of this announcement.
About Prince Foundation
Prince Foundation, founded in 2015, is one of Cambodia's leading philanthropic foundations. A member of Prince Holding Group, which is one of the largest business groups in Cambodia, the Foundation aims to work with local communities to build thriving living and working environments that elevate people's well-being and livelihoods, following the vision: "Together, Building a Better Future for Cambodia."
Focusing on education and youth development, healthcare, and community engagement and sports, and healthcare initiatives, Prince Foundation works with partners to deliver sustainable programs that enhance opportunities for Cambodia's youths, build resilience in communities, and contribute to sustainable infrastructure.
The Foundation's flagship projects are the Chen Zhi Scholarship, offering full scholarships, stipends, internships, and work opportunities to 400 Cambodian university students over a period of seven years, and Prince Horology, where aspiring Cambodian watchmakers learn the art of Swiss-style watchmaking in a state-of-the-art facility. Prince Foundation has launched more than 280 philanthropic initiatives, benefiting over 1.5 million people, with donations exceeding US$18 million.
Prince Foundation
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
12-07-2025
- Zawya
Wegovy® (semaglutide 2.4mg) by Novo Nordisk is now Available in Singapore for Weight Management
Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least one related health condition. The once-weekly injectable supports weight loss when used alongside a reduced-calorie diet and increased physical activity. The launch marks a step toward evidence-based, compassionate treatment of obesity as a chronic disease—not a personal failing. SINGAPORE - Media OutReach Newswire - 12 July 2025 - A significant advancement in weight management has arrived for Singaporeans. Novo Nordisk, a global healthcare company focused on defeating serious chronic diseases, has announced the availability of Wegovy ® (semaglutide 2.4mg) in Singapore. Wegovy® (semaglutide 2.4mg) is a once-weekly injectable treatment indicated for chronic weight management in adults and adolescents (aged 12 and above) living with obesity (BMI ≥30 kg/m²), or who are overweight (BMI ≥27 kg/m² to <30 kg/m²) with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia 1. It is used alongside a reduced-calorie diet and increased physical activity, supporting Singapore's efforts to improve population health. The treatment works by addressing one of the underlying biological drivers of obesity. Wegovy® (semaglutide 2.4mg) is a GLP-1 receptor agonist with 94% similarity to the body's natural GLP-1 hormone. It activates receptors involved in appetite regulation, helping individuals feel full sooner and reduce food intake 1. This mechanism supports weight loss when combined with sustainable lifestyle changes. The availability of Wegovy® (semaglutide 2.4mg) comes as obesity continues to pose a significant health burden in Singapore. An estimated 600,000 adults are currently living with obesity 2 - 4, a condition associated with more than 200 health complications 5. Despite its prevalence and medical complexity, obesity remains heavily stigmatised—often misunderstood as merely the result of poor personal choices. Individuals living with obesity frequently face discrimination and mental health challenges which further isolate them. This misplaced blame, rather than targeting the disease itself, creates barriers to and slows the advancement of effective obesity treatment. Recognised by World Health Organization as a chronic disease 6, obesity requires compassionate evidence-based care. The launch of Wegovy® (semaglutide 2.4mg) in Singapore provides a new treatment option for weight management available through private prescription. Dr Abel Soh, Abel Soh Diabetes, Thyroid and Endocrine Clinic and Chairperson for Endocrine and Metabolic Society of Singapore (EMSS) stated, "Obesity is not simply the result of lifestyle choices — it is a medically recognised chronic disease influenced by a complex interplay of genetics, hormones, and environment. In my clinical practice, I see firsthand how many individuals blame themselves when in fact, their biology is often working against them. It's time we shift the conversation from blame to support in the management of individuals with obesity" Lifestyle factors in Singapore further contribute to the challenge. In Singapore's demanding work culture—where full-time employees work an average of 44.6 hours per week 7, with time constraints and fatigue frequently cited as barriers to maintaining regular physical activity. These circumstances underscore the importance of comprehensive treatment strategies that facilitate the adoption of healthier lifestyles, including increased physical activity and a reduced-calorie diet, as integral components of long-term weight management. Mr Vincent Siow, General Manager, Novo Nordisk Singapore, said "With treatments like Wegovy ® (semaglutide 2.4mg) now available in Singapore, we have an opportunity to provide healthcare professionals with more evidence-based options to support their patients in regaining control of their health and improving long-term outcomes." References: Wegovy Singapore Prescribing Information, February 2025 Cuciureanu M, Caratașu CC, Gabrielian L, Frăsinariu OE, Checheriță LE, Trandafir LM, Stanciu GD, Szilagyi A, Pogonea I, Bordeianu G, Soroceanu RP, Andrițoiu CV, Anghel MM, Munteanu D, Cernescu IT, Tamba BI. 360-Degree Perspectives on Obesity. Medicina (Kaunas). 2023 Jun 9;59(6):1119. doi: 10.3390/medicina59061119. PMID: 37374323; PMCID: PMC10304508. World Obesity. Retrieved from World Obesity. Retrieved from Scott I. Kahan, MD, MPH. Practical Strategies for Engaging Individuals With Obesity in Primary Care. Mayo Clin Proc. 2018;93(3):351-359 2. CDC, Cancers Associated with Overweight and Obesity Makeup 40 percent of Cancers Diagnosed in the United States. Available at World Health Organization. (2024). Obesity and overweight. As accessed on 22nd May 2025. Leu J, Rebello SA, Sargent GM, Kelly M, Banwell C. Hard work, long hours, and Singaporean young adults' health. A qualitative study. Frontiers in Public Health. 2023; 11. Hashtag: #NovoNordisk #Wegovy The issuer is solely responsible for the content of this announcement. About Novo Nordisk Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs around 77,400 people in 80 countries and markets its products in around 170 countries. In Singapore, Novo Nordisk has been present since 1997 and has approximately 100 employees. For more information, visit Novo Nordisk
Zawya
09-07-2025
- Zawya
Prince Foundation Extends Support for Children's Healthcare in Cambodia Through Cambodia Kantha Bopha Foundation, Reflecting Commitment Guided by Neak Oknha Chen Zhi
PHNOM PENH, CAMBODIA - Media OutReach Newswire - 9 July 2025 - Prince Foundation, the philanthropic arm of Prince Holding Group under the leadership of Neak Oknha Chen Zhi, has reaffirmed its ongoing support for children's healthcare in Cambodia by joining the Cambodia Kantha Bopha Foundation's (CKF) 2025 national fundraising campaign. The Foundation participated in the official campaign launch on June 1, presided over by First Lady Lok Chumteav Dr. Pich Chanmony Hun Manet and Deputy Prime Minister H.E. Dr. Aun Pornmoniroth, alongside senior government officials, civil society organizations, and private sector leaders. As part of its continued engagement with CKF, Prince Foundation also led a company-wide internal donation drive across all business units of Prince Holding Group. The initiative invited employees to contribute to solidarity with the national effort, reflecting the shared belief across the organization in supporting access to free pediatric healthcare. Staff gathered at the Group's headquarters in Phnom Penh to make their donations, reinforcing a culture of giving that aligns with the Foundation's values. The 2025 CKF campaign, under the theme "10K Riel, 10K Donors," encourages individuals and organizations to donate 10,000 Cambodian Riel (approximately US$2.50) each to sustain the critical services offered by Kantha Bopha hospitals, which provide free, life-saving medical care for children throughout the country. "Healthcare is a shared responsibility, and we are committed to standing with others in supporting Cambodia's children," said Mr. Gabriel Tan, Head of Prince Foundation. "We are proud of the enthusiastic participation of our colleagues across Prince Group, and we hope more members of the public and private sectors will join in contributing to this meaningful campaign." Since 2015, Prince Foundation—guided by the philanthropic vision of Neak Oknha Chen Zhi — has contributed to the Cambodia Kantha Bopha Foundation, as part of a long-standing commitment to support sustainable and inclusive healthcare in Cambodia. Prince Foundation encourages others to support this important initiative and contribute to ensuring all children in Cambodia can access the healthcare they need to grow and thrive. For more information about the Cambodia Kantha Bopha Foundation and how to contribute, please visit Hashtag: #PrinceFoundation The issuer is solely responsible for the content of this announcement. About Prince Foundation Prince Foundation, founded in 2015, is one of Cambodia's leading philanthropic foundations. A member of Prince Holding Group, which is one of the largest business groups in Cambodia, the Foundation aims to work with local communities to build thriving living and working environments that elevate people's well-being and livelihoods, following the vision: "Together, Building a Better Future for Cambodia." Focusing on education and youth development, healthcare, and community engagement and sports, and healthcare initiatives, Prince Foundation works with partners to deliver sustainable programs that enhance opportunities for Cambodia's youths, build resilience in communities, and contribute to sustainable infrastructure. The Foundation's flagship projects are the Chen Zhi Scholarship, offering full scholarships, stipends, internships, and work opportunities to 400 Cambodian university students over a period of seven years, and Prince Horology, where aspiring Cambodian watchmakers learn the art of Swiss-style watchmaking in a state-of-the-art facility. Prince Foundation has launched more than 280 philanthropic initiatives, benefiting over 1.5 million people, with donations exceeding US$18 million. Prince Foundation
Zawya
04-07-2025
- Zawya
Wishpro Launches Advanced Magnetic Infusion Technology for Smarter Skin Management
KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 4 July 2025 - In a world flooded with skincare promises, most products barely scratch the surface. Wishpro launches its first patented Magnetic Infusion Technology (MIT) system, engineered to deliver visible skin transformation. Wishpro embraces the power of oil-based actives — an often-overlooked yet essential approach in our humid and changing climate. While many products focus on water-based formulas, Wishpro's oil-based serums help strengthen the skin barrier, improve moisture retention, and offer deeper nourishment without clogging pores. It's a perfect match for modern skin needs. The Future of Skin Health, Powered by Magnetic Infusion At the heart of Wishpro is a revolutionary technology: Magnetic Infusion Technology (MIT). Unlike surface-level creams and serums, Wishpro uses electromagnetic pulses to gently open microchannels in the skin, allowing highly active ingredients to reach deeper layers, where real change happens. Paired with precision-formulated, single-use serum capsules, this synergy of technology and formulation unlocks a new category of skin management: non-invasive, high-performance, and clinically proven. More Than a Device: A Clinical-Grade Treatment Wishpro delivers dermatologist-trusted results through four interchangeable treatment heads—Red Light, Blue Light, Microcurrent, and Exfoliation—customizable to meet evolving skin needs. Watch the full testimonial: This red blood cell activation supercharges the skin's ability to heal, regenerate, and absorb nutrients, turning every session into a transformation. Smart Design, Built for Real Life Wishpro's signature donut-shaped capsule ensures direct and even contact with the skin, while its compact, ergonomic build makes it lightweight and effortless to use. Wishpro blends clinical-grade performance with everyday convenience each treatment takes only 15 minutes, making it the ideal solution for those who want fast results without disrupting their routine. Targeted Serum Capsules, Powered by Science Wishpro offers a suite of 13 RFID-enabled serum capsules, each formulated to treat specific concerns—from dullness and hyperpigmentation to acne, sensitivity, and visible aging. Each capsule is: Clinically formulated with powerful active ingredients Individually sealed for hygiene and safety Designed for maximum absorption, activated by Wishpro's infusion technology More than just two capsules have demonstrated efficacy and clinical studies. A few highlights include: β-White (Brightening Capsule): A biomimetic peptide that reduces melanin production by up to 79%, with a 30% visible reduction in dark spots within 56 days. Biogomm'age (Peel Exfoliator Capsule): More than just an exfoliator, this capsule features biodegradable, non-irritant safe scrub technology, enriched with Vitamin B5 and Vitamin E. Clinically shown to deliver softer, smoother skin with minimal irritation, it is preferred by 79% of users over traditional scrubs. Neodermyl® (Neo Energy Capsule): Clinically proven to significantly increase collagen density (up to 7.6 times), improve skin firmness by up to 13 times, and visibly reduce wrinkle depth and volume by 15% in just 15–60 days. The hero ingredient, Neodermyl®, is a gold-standard anti-aging molecule with powerful skin rejuvenation effects. The Wishpro Philosophy: Where Beauty Meets Innovation Wishpro isn't just another beauty gadget, it's a mission to professionalize everyday skincare. The name itself blends"wish" with "professional," reflecting a brand ethos rooted in real results, proven science, and smart design. In a world that demands efficacy, hygiene, and time efficiency, Wishpro delivers all three, plus the power to adapt treatments to individual skin needs. It's a future-ready system that empowers users to take control of their skin journey from the very first session. Final Thought: Skincare That Doesn't Just Work, It Works Smarter Wishpro has redefined what's possible in non-invasive skincare. Backed by clinical research, global dermatologists, and real users, it offers more than beauty - it offers confidence, credibility, and visible transformation. For more information, contact: +65 6292 0100, or visit Hashtag: #Wishpro The issuer is solely responsible for the content of this announcement. Wishpro
